首页 | 本学科首页   官方微博 | 高级检索  
检索        

三七总皂苷联合阿糖胞苷对K562细胞的影响
引用本文:崔玲玲,尹利明,郑智茵.三七总皂苷联合阿糖胞苷对K562细胞的影响[J].浙江中医药大学学报,2012,36(9):1025-1028.
作者姓名:崔玲玲  尹利明  郑智茵
作者单位:1. 浙江中医药大学 杭州310053
2. 浙江中医药大学附属第一医院
摘    要:目的]考察三七总皂苷联合应用阿糖胞苷对白血病细胞K562细胞活力、增殖抑制、诱导凋亡的协同作用.方法]处于对救生长期的白血病K562细胞,给予三七总皂苷、阿糖胞苷以及两药的联合,采用MTT试验、集落形成实验、Annexin V-PI双染流式细胞检测等实验手段进行分析检测.结果]单用三七总皂苷对K562白血病细胞有一定的增殖抑制作用,对抑制集落形成和诱导凋亡作用不明显;相同剂量的三七总皂苷联用阿糖胞苷后,对K562细胞的增殖抑制、集落形成和凋亡有明显的增强.结论]三七总皂苷联用阿糖胞苷对白血病细胞K562有明显的抗肿瘤作用,提示三七总皂苷可提高白血病细胞对化疗药物的敏感性,为临床用三七总皂苷抗白血病的辅助治疗提供依据.

关 键 词:白血病  K562细胞  三七总皂苷  阿糖胞苷  联合用药

The Effect of Combined Administration of Panax Notoginseng Saponins and Cytarabine on K562 Cells
Cui Lingling , Yin Liming , Zheng Zhiyin.The Effect of Combined Administration of Panax Notoginseng Saponins and Cytarabine on K562 Cells[J].Journal of Zhejiang University of Traditional Chinese Medicine,2012,36(9):1025-1028.
Authors:Cui Lingling  Yin Liming  Zheng Zhiyin
Institution:.Zhejiang Chinese Medical University,Hangzhou(310053),China;2.The First Affiliated Hospital,Zhejiang Chinese Medical University
Abstract:Objective] In order to investigate Panax notoginseng saponins combined with cytarabine in leukemia K562 cell viability,proliferation inhibition and synergistic induction of apoptosis.Methods] Leukemia K562 cells in the logarithmic growth phase,given Panax notoginseng saponins,cytarabine,and two-drug combination,using the MTT assay,colony formation assay,Annexin V-PI double staining flow cytometry experimentsanalysis and detection.Results] Single Panax notoginseng saponins on K562 cells proliferation inhibition,inhibition of colony formation and induction of apoptosis is not obvious;the same dose of Panax notoginseng saponins combined with cytarabine on K562 cellsinhibition of proliferation,colony formation and apoptosis are greatly enhanced.Conclusion] PNS associated with cytarabine leukemia K562 cells has significant anti-tumor effect,suggesting that Panax notoginseng saponins can increase the sensitivity of leukemia cells to chemotherapeutic drugs,and provide the basis for the clinical use of adjuvant therapy of anti-leukemia.
Keywords:leukemia  K562 cells  Panax notoginseng saponins  cytarabine  combination medication
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号